NovoMic

Dry Lice Treatment

Health Tech & Life Sciences
Acquired by TRAISTMAN RADZIEJEWSKI FUNDACJA
Acquired Rosh Haayin Founded 2014
Total raised
$1.0M
Last: Seed 2014-08
Stage
Acquired
Founded
2014
Headcount
6
HQ
Rosh Haayin
Sector
Health Tech & Life Sciences

About

Novomic produces Novokid, a quick, easy, 100% natural dry treatment for lice and nits. Novokids patented technology vaporizes natural plant-based ingredients for treatment against lice and nits. The product is free from chemicals, pesticides, and silicon and is CE approved and certified by the MHRA and the Israeli Ministry of Health. In October 2016, Novomic merged with BreedIT to create a new company, TechCare, and had been operating as a wholly owned subsidiary of TechCare. In January 2020, TechCare entered into a share purchase agreement with Traistman Radziejewski Fundacja Ltd, which acquired 90% of Novomics issued and outstanding capital stock held by TechCare.

Funding history · 1 round · $1.0M total

2014-08
Seed $1.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
ConsumersDemographics & FamilyChildren
Business model
B2C

Highlights

1 Patents

Tags

home-carehygienemedical-productschildrenmedical-technologiestreatments